Instructions for Documenting Qualification Activities Posted on June 8, 2021February 6, 2025 by Hannah Faulkner Instructions for Documenting Qualification Activities
Documenting Qualification: A Quick-Reference Guide for Investigators and their Delegates Posted on June 8, 2021February 6, 2025 by Hannah Faulkner Documenting Qualification: A Quick-Reference Guide for Investigators and their Delegates
Recommendations for Identifying Qualified Investigators and Their Delegates to Conduct Sponsored Clinical Trials Posted on June 8, 2021February 6, 2025 by Hannah Faulkner Recommendations for Identifying Qualified Investigators and Their Delegates to Conduct Sponsored Clinical Trials
Recommendations for Strengthening the Investigator Site Community Posted on June 8, 2021February 6, 2025 by Hannah Faulkner Recommendations for Strengthening the Investigator Site Community
Recommendations for Informed Consent Posted on June 8, 2021February 5, 2025 by Hannah Faulkner Recommendations for Informed Consent
Sample Tiered Informed Consent Model Posted on June 8, 2021February 5, 2025 by Hannah Faulkner Sample Tiered Informed Consent Model
Informed Consent Training Resources Posted on June 8, 2021February 5, 2025 by Hannah Faulkner Informed Consent Training Resources
Recommendations for Good Clinical Practice (GCP) Training for Investigators Posted on June 8, 2021February 6, 2025 by Hannah Faulkner Recommendations for Good Clinical Practice (GCP) Training for Investigators
Recommendations for Improving Reporting of Unexpected Serious Adverse Events (SAEs) to Investigation New Drug (IND) Investigators Posted on June 8, 2021February 11, 2025 by Hannah Faulkner Recommendations for Improving Reporting of Unexpected Serious Adverse Events (SAEs) to Investigation New Drug (IND) Investigators
Evaluating Feasibility of RWD-Supported Recruitment Posted on June 8, 2021February 10, 2025 by Hannah Faulkner Evaluating Feasibility of RWD-Supported Recruitment
